What Hjorring can do?

Cardiovascular and renal disease,climate change and a more resilient future

Discouer our stories of impact >

Unique regulatory challenges

As ‘living medicines’, cell therapies require a separate regulatory framework that has been evolving over recent years.

What are viral variants and how do they emerge?

The global impact of digital transformation in the last few decades cannot be understated.

Keep up to date with the latest news

“Imagine if a small blood sample could tell you everything you want to know about the presence and origin of cancer within the body, to help clinicians select the best treatment for patients and then monitor how……”

View more

Novel genetic targets for fatty liver disease

Advances in understanding of disease biology and major innovations in gene sequencing and data analysis has created a highly fertile scientific environment to support significant progress in the identification of genetic variants for non-alcoholic steatohepatitis (NASH).

View more
We have

198

projects in our pipeline

View more

Achieving regulatory success in cell therapy →

Why taking a multifaceted approach…… →

Leading Cardiovascular,Renal and Metabolism InnovationLeading Cardiovascular,Renal and Metabolism Innovation →

Creating better health outcomes with a holistic approachh towards →